Public Company News
2026 ASCO Preview | Results from Phase III Study of Anbenitamab (KN026) Combined with HB1801 in Neoadjuvant Treatment for Breast Cancer Selected for LBA Oral Presentation
SUZHOU, China, April 22, 2026 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) today announced that the significant results from the Phase III clinical study (KN026-004) of HER2 bispecific antibody Anbenitamab Injection (KN026), independently developed by the Company, and co-developed with...
2026-04-22 14:10
903
XCMG Hydrogen-Powered Heavy Truck Completes "Hydrogen Marathon" Verification, Advancing Low-Carbon Heavy Transport
XUZHOU, China, April 22, 2026 /PRNewswire/ -- As Earth Day underscores this year's theme, "Our Power, Our Planet," global momentum toward low-carbon transition continues to accelerate. Against this backdrop, XCMG's hydrogen-powered heavy truck has successfully completed China's first full-indust...
2026-04-22 13:53
2995
Rockwell Automation Brings Industry Leaders Together at ROKLive Jakarta 2026, Shaping the Future of Industrial Operations
Highlighting innovations in AI, digitalization and energy management, the event explored how emerging technologies are transforming Indonesia's industrial operations JAKARTA, Indonesia, April 22, 2026 /PRNewswire/ -- Rockwell Automation, the world's largest company dedicated to industrial automa...
2026-04-22 13:30
2995
Kelun-Biotech Announces Three Clinical Study Results Selected for Oral Presentations at 2026 ASCO Annual Meeting
CHENGDU, China, April 22, 2026 /PRNewswire/ -- The 2026 American Society of Clinical Oncology (ASCO) Annual Meeting will be held in Chicago from May 29 to June 2. In this meeting, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK) will present results from three clinical studies, includi...
2026-04-22 08:59
2712
Case Report of Mabwell's Nectin-4 targeting ADC (9MW2821) in Cervical Cancer Published in The New England Journal of Medicine
SHANGHAI, April 22, 2026 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industrial chain, announced that a recent clinical case report on its self-developed novel Nectin-4 ADC (bulumtatug fuvedotin, R&D code: 9MW2821) for the treatment ...
2026-04-22 08:00
2772
Innovent to Present New Clinical Data of IBI363（PD-1/IL-2α-biased bispecific fusion protein） at the 2026 ASCO Annual Meeting
SAN FRANCISCO and SUZHOU, China, April 21, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmun...
2026-04-22 08:00
2375
ViGenCell's VT-EBV-N Selected for Oral Presentation at ASCO 2026
Phase 2 study of EBV-specific T cell therapy to be presented at a leading oncology meeting SEOUL, South Korea, April 21, 2026 /PRNewswire/ -- ViGenCell Inc. (KOSDAQ: 308080), a clinical-stage biotechnology company based in South Korea focused on advanced cell therapies, today announced that resu...
2026-04-22 07:30
2269
Health In Tech to Present at the Market Movers Investor Summit
STUART, Fla., April 21, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) (the "Company"), an AI-enabled InsurTech platform company, today announced that it will be participating in the Market Movers Investor Summit on Tuesday, May 5, 2026. The Company's presentation, led by Julia Qian, CFO...
2026-04-22 04:00
3410
CATL Unveils Six Major Innovations: Multi-Chemistry Systems to Redefine New Energy Mobility Experience
BEIJING, April 22, 2026 /PRNewswire/ -- CATL today hosted its Super Technology Day in Beijing, unveiling third-generation Shenxing Superfast Charging Battery, third-generation Qilin Battery, Qilin Condensed Battery, second-generation Freevoy Super Hybrid Battery, Naxtra Sodium-ion Battery and a f...
2026-04-22 02:41
3439
HCLTech FY26 revenue up 3.9%, led by increasing demand for Advanced AI
Annualized Advanced AI revenue at $620M; FY26 services revenue up 4.8% in CC;
TCV of new deal wins at $9.3B
NEW YORK and NOIDA, India, April 22, 2026 /PRNewswire/ -- HCLTech
2026-04-22 01:44
3015
Annual general meeting of AB SKF
GOTHENBURG, Sweden, April 21, 2026 /PRNewswire/ -- The annual general meeting of Aktiebolaget SKF was held on Tuesday 21 April 2026. The income statement and balance sheet and the consolidated income statement and consolidated balance sheet were adopted. A dividend of SEK 7.75 per share to be pa...
2026-04-21 22:00
2326
Joyson Electronics Unveils First-ever Sustainability Dual Reports, Sets 2040 Core-Operations Net-Zero Target
HONG KONG and NINGBO, China, April 21, 2026 /PRNewswire/ -- Joyson Electronics (0699.HK) has, for the first time, released two sustainability-related reports in tandem—its Sustainability Report 2025 and Nature-related Disclosures Report 2025. It continues to embed sustainability into its strategy...
2026-04-21 21:48
3775
Massimo Expands Fleet Network and Advances Second-Generation Autonomous Patrol Platform
Growing deployment across facility-based environments and enhanced autonomous capabilities support broader commercial applications GARLAND, Texas, April 21, 2026 /PRNewswire/ -- Massimo Motor today announced the continued expansion of its electric vehicle fleet network across municipal, commerci...
2026-04-21 21:25
4152
Cognizant and OpenAI Partner to Reshape Enterprise Software Engineering with Codex
Recognized by OpenAI for its AI builder capabilities, Cognizant is embedding Codex across its global software engineering organization and working with OpenAI to bring Codex-driven development to clients across industries. TEANECK, N.J., April 21, 2026 /PRNewswire/ -- Cognizant (NASDAQ: CTSH) a...
2026-04-21 21:15
4875
EZGO Takes Full Legal Ownership of Its Self-Built Changzhou Manufacturing Facility to Scale Production
CHANGZHOU, China, April 21, 2026 /PRNewswire/ -- EZGO Technologies Ltd. (Nasdaq: EZGO) ("EZGO" or the "Company"), a short-distance transportation solutions provider in China, today announced that its subsidiary, Jiangsu EZGO New Energy Technology Co., Ltd., has received the real estate ownership ...
2026-04-21 21:15
3067
Insilico Medicine Announces Industry's First Longevity Board to Accelerate AI-Driven Aging Research for Drug Discovery
CAMBRIDGE, Mass., April 21, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced the strategic formation of the industry's first Longevity Board (Board). The initiative provides scienti...
2026-04-21 21:05
3436
NYSE Content Update: UiPath Celebrates Five-Year Listing Anniversary at NYSE
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, April 21, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begi...
2026-04-21 20:55
3944
Getinge Interim Report January-March 2026: Organic growth, strong cash flow and regulatory milestone
GOTHENBURG, Sweden, April 21, 2026 /PRNewswire/ -- "We succeeded in surpassing last year's record-breaking first quarter with organic growth in both net sales and order intake," says Mattias Perjos, President & CEO at Getinge. The medtech company's net sales increased organically by 0.8% while th...
2026-04-21 20:36
2120
Minaris Delivers 100% Manufacturing and Release Success for Chimeric Therapeutics' CDH17 Autologous CAR‑T Program
Five-year collaboration supports consistent clinical supply for Phase 1A/1B GI cancer study PHILADELPHIA and MELBOURNE, Australia, April 21, 2026 /PRNewswire/ -- Minaris, a global cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) and multimodality biosafety t...
2026-04-21 20:00
2306
Celltrion to present seven abstracts in inflammatory bowel disease (IBD) at 2026 Digestive Disease Week® (DDW)
* Seven abstracts accepted for presentation include data from long-term follow-up studies and a post-hoc analysis of the pivotal LIBERTY studies (LIBERTY-CD and LIBERTY-UC) of ZYMFENTRA® (infliximab-dyyb) * Findings emphasize clinical decision-making in long-term management of inflammatory bo...
2026-04-21 20:00
2791
Week's Top Stories
Most Reposted
Singapore imagines new ways of living at Milan Design Week with the opening of Prototype Island
[Picked up by 304 media titles]
2026-04-21 10:28
HKBU Symphony Orchestra Annual Gala Concert to integrate digital technology and artificial intelligence
[Picked up by 303 media titles]
2026-04-27 21:47
Blaize and Datacomm Sign Technology Alliance MOU to Explore AI Inference Solutions Across Indonesia
[Picked up by 295 media titles]
2026-04-21 18:00
THAIFEX - Anuga Asia 2026 Returns As the Industry's Business Catalyst -- at a Time the F&B Sector Needs It Most
[Picked up by 295 media titles]
2026-04-23 11:00Dragonpass Empowers Financial Institutions with End-to-End Loyalty Solutions at Money20/20 Asia
[Picked up by 287 media titles]
2026-04-23 14:43
Most Read
Blaize and Datacomm Sign Technology Alliance MOU to Explore AI Inference Solutions Across Indonesia
2026-04-21 18:00
5863
/C O R R E C T I O N -- TCL/
2026-04-22 12:01
5174
RoboSense Unveiled EOCENE SPAD-SoC Architecture and Chipsets Phoenix and Peacock: Ushering the LiDAR Industry into the Image-grade Era of High-Definition 3D Perception
2026-04-21 15:55
5090
/C O R R E C T I O N -- Empyrion Digital/
2026-04-21 12:25
4942
Cognizant and OpenAI Partner to Reshape Enterprise Software Engineering with Codex
2026-04-21 21:15
4860